Codexis, Inc. revenue for the last year amounted to 70.14 M USD, the most of which — 42.91 M USD — came from its highest performing source at the moment, Biocatalysts, Pharmaceutical Intermediates, and Codex Biocatalyst Panels and Kits. The greatest contribution to the revenue figure was made by China — last year it brought Codexis, Inc. 20.30 M USD.